2 most recent filings and news items mentioning STXS. Updated every 60 seconds.
M&AJul 15, 2026Negative
Stereotaxis filed an 8-K highlighting risks related to the recently completed acquisition of Robocath. The company addresses potential disruptions and integration hurdles that could delay expected synergies.
View filing at SEC.gov →
M&AJul 9, 2026Positive
Stereotaxis completed the acquisition of Robocath to combine technologies and strengthen its market position. This strategic move is expected to accelerate innovation and expand the addressable market for endovascular robotic solutions.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.